Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy.

@article{Totani2015ReactivationOH,
  title={Reactivation of hepatitis B virus (HBV) infection in adult T-cell leukemia-lymphoma patients with resolved HBV infection following systemic chemotherapy.},
  author={Haruhito Totani and Shigeru Kusumoto and Takashi Ishida and Arisa Masuda and Takashi Yoshida and Asahi Ito and Masaki Ri and Hirokazu Komatsu and Shuko Murakami and Masashi Mizokami and Ryuzo Ueda and Akio Niimi and Hiroshi Inagaki and Yasuhito Tanaka and Shinsuke Iida},
  journal={International journal of hematology},
  year={2015},
  volume={101 4},
  pages={398-404}
}
Reactivation of hepatitis B virus (HBV) infection may occur in adult T-cell leukemia-lymphoma (ATL) patients with resolved HBV infection who receive monotherapy with the anti-CC chemokine receptor 4 monoclonal antibody, mogamulizumab. However, there is little evidence regarding the incidence and characteristics of HBV reactivation in ATL patients receiving systemic chemotherapy, including the use of this antibody. We conducted a retrospective study for 24 ATL patients with resolved HBV… CONTINUE READING